Hims Hers Health Inc(HIMS)— 技術面狀態
數據截至2026-09-21 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades -2.5% vs the 50-day and +5% vs the 200-day average, 55.1% below the 52-week high and +113.6% off the 52-week low; a golden cross printed 37 sessions ago. Computed from daily closes.
Ranked #14 on today’s Directional Flow — Steady builders list (scan of 2026-09-21).
移動平均線狀態
- 相對20日均線+1.9%
- 相對50日均線-2.5%
- 相對200日均線+5%
- 52週區間低於52週高點55.1% · 高於52週低點113.6%
- 連續走勢連續2個交易日上漲
- 均線交叉黃金交叉(37個交易日前)
- 50日均線交叉股價向下穿越50日均線(19個交易日前)
- 隨機指標%K 83.4 · %D 29.7(黃金交叉)
FAQ · from the current data · as of 2026-09-21
Quick answers
HIMS目前的Closelook訊號是什麼?
Pullback inside an uptrend stack — Trades -2.5% vs the 50-day and +5% vs the 200-day average, 55.1% below the 52-week high and +113.6% off the 52-week low; a golden cross printed 37 sessions ago. Computed from daily closes.(截至2026-09-21;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
HIMS目前是否位於50日與200日均線上方?
截至2026-09-21,Hims Hers Health Inc位於50日均線下方(-2.5%),200日均線上方(+5%);距20日均線+1.9%。
HIMS距52週高點有多遠?
截至2026-09-21,低於52週高點55.1%,高於52週低點113.6%。
Related in the Closelook universe
then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- LNTH Lantheus Holdings Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- AMRX Amneal Pharmaceuticals, Inc. Class A Common Stockindustry
- BHC.TO Bausch Health Companies Incindustry
- ALKS Alkermes Plcindustry
- HCM.L HUTCHMED China Ltdindustry
- PRGO Perrigo Company PLCindustry
- VTRS Viatris Incindustry
- RDY Dr. Reddy’s Laboratories Ltd ADRindustry
- DMP.DE Dermapharm Holding SEindustry
- UTHR United Therapeutics Corporationindustry
- ZTS Zoetis Incindustry
- GALDY GALDERMA GROUP AGindustry
- ELAN Elanco Animal Healthindustry
- NBIX Neurocrine Biosciences Incindustry
- DXCM DexCom Incsector
- ARGX argenx NV ADRsector
- ONC BeiGene, Ltd.sector
- MEDP Medpace Holdings Incsector